News

Filter

Current filters:

None

Popular Filters

1 to 25 of 8753 results

Shire confirms it has entered into talks with AbbVie

12-07-2014

Following reports by the Bloomberg news service, on Friday Ireland-based drugmaker Shire confirmed that…

Mergers & AcquisitionsNeurologicalPharmaceuticalRare diseases

EUCOPE slams French plans to cut spending through off-label drugs

12-07-2014

The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) says it is very concerned about legislative…

AvastinEuropeFranceLegalOphthalmicsPharmaceuticalRegulationRoche

US Senators press for details on Gilead’s Sovaldi pricing

12-07-2014

Adding to previous criticism from the likes of the medical humanitarian organization Medecins Sans Frontieres…

Anti-viralsBiotechnologyGilead SciencesPoliticsPricingSovaldiUSA

Actavis confirms patent challenge to Duchesnay’s Diclegis

12-07-2014

Ireland-based generics major Actavis on Friday confirmed that it has filed an Abbreviated New Drug Application…

ActavisDiclegisDuchesnayGenericsPatentsRegulationUSAWomen's Health

NICE issues positive draft FAD guidance on Tecfidera

NICE issues positive draft FAD guidance on Tecfidera

11-07-2014

UK health care cost watchdog the National Institute for Health and Care Excellence (NICE) has issued…

Biogen IdecBiotechnologyMultiple sclerosisNeurologicalPricingRegulationTecfideraUK

Jounce appoints Richard Murray from Merck

Jounce appoints Richard Murray from Merck

11-07-2014

US-based oncology specialist Jounce Therapeutics has announced the appointment of Richard Murray to chief…

BoardroomJounce TherapeuticsMerck & Co.OncologyPharmaceuticalRichard Murray

UK cancer patients face increasing coverage restriction, US report shows

UK cancer patients face increasing coverage restriction, US report shows

11-07-2014

New US research released yesterday quantifies the extent to which centralized value assessments by the…

OncologyPharmaceuticalPricingRegulationUK

Servier to appeal EC fine over perindopril

Servier to appeal EC fine over perindopril

11-07-2014

French privately-held drugmaker Servier has said it will appeal before the European Union Court of Justice…

Cardio-vascularEuropeFinancialLegalPerindoprilperindoprilPharmaceuticalServier

European Medicines Agency approves fewer drugs in first half of 2014 than same period in 2013

European Medicines Agency approves fewer drugs in first half of 2014 than same period in 2013

11-07-2014

The European Medicines Agency’s Committee for Medicinal Products from Human Use (CHMP) recommended…

Clinical researchEuropean Medicines Agency

Celgene’s Imnovid now reimbursed in Sweden, Spain and Switzerland

Celgene’s Imnovid now reimbursed in Sweden, Spain and Switzerland

11-07-2014

US biotech firm Celgene’s Imnovid (pomalidomide), called Pomalyst in the USA, is now approved for reimbursement…

BiotechnologyCelgeneFinancialHealthcareImnovidOncologyPomalystSpainSweden

Sanofi Pasteur releases pivotal Ph III results from dengue vaccine study

Sanofi Pasteur releases pivotal Ph III results from dengue vaccine study

11-07-2014

Sanofi Pasteur, the vaccines division of French drug major Sanofi, has announced detailed results of…

FrancePharmaceuticalResearchSanofi PasteurVaccines

Ipsen and Galderma expand neurotoxins partnership

Ipsen and Galderma expand neurotoxins partnership

11-07-2014

French drugmaker Ipsen and global dermatology and skin health company Galderma have expanded the scope…

Botulinum toxinDermatologicalsGaldermaGalderma InternationalIpsen

Oxford BioTherapeutics appoints Eugen Leo as head of clinical development

Oxford BioTherapeutics appoints Eugen Leo as head of clinical development

11-07-2014

UK-based biotech company Oxford BioTherapeutics, focusing on antibody-drug conjugates in the treatment…

BiotechnologyBoardroomOxford BioTherapeuticsUK

Sarepta tanks despite positive data on eteplirsen in Duchenne MD

Sarepta tanks despite positive data on eteplirsen in Duchenne MD

11-07-2014

US RNA-based drug developer Sarepta Therapeutics saw its shares plunge, despite the company releasing…

BiotechnologyeteplirsenRare diseasesRegulationResearchSarepta TherapeuticsUSA

Bristol-Myers to file Opdivo BLA earlier than expected

Bristol-Myers to file Opdivo BLA earlier than expected

10-07-2014

Following discussions with the US Food and Drug Administration, Bristol-Myers Squibb is planning a third…

Bristol-Myers SquibbnivolumabOncologyOpdivoPharmaceuticalRegulationUSA

1 to 25 of 8753 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top